Fate Therapeutics Stock Investor Sentiment
| FATE Stock | USD 0.91 0.01 1.09% |
About 60% of Fate Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Fate Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Fate Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Fate Therapeutics stock news signals to limit their universe of possible portfolio assets.
Comfort Level 40
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Fate Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Fate Therapeutics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Fate Historical Sentiment
Although Fate Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Fate, such as negative comments on social media and news outlets, may cause fear in the market and push Fate Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Fate.
Fate |
Fate Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Fate Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Fate Therapeutics Historical Investor Sentiment
Investor biases related to Fate Therapeutics' public news can be used to forecast risks associated with an investment in Fate. The trend in average sentiment can be used to explain how an investor holding Fate can time the market purely based on public headlines and social activities around Fate Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Fate Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Fate Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Fate Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Fate Therapeutics.
Far too much social signal, news, headlines, and media speculation about Fate Therapeutics that are available to investors today. That information is available publicly through Fate media outlets and privately through word of mouth or via Fate internal channels. However, regardless of the origin, that massive amount of Fate data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fate Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fate Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fate Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fate Therapeutics alpha.
Fate Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 56331 shares by Redmile Group, Llc of Fate Therapeutics at 3.02 subject to Rule 16b-3 | 12/20/2024 |
2 | Disposition of 8705 shares by Bahram Valamehr of Fate Therapeutics at 1.54 subject to Rule 16b-3 | 01/10/2025 |
3 | Acquisition by Jerome Bressi of 250000 shares of Fate Therapeutics at 1.32 subject to Rule 16b-3 | 01/15/2025 |
4 | Acquisition by Bahram Valamehr of 1300000 shares of Fate Therapeutics at 1.25 subject to Rule 16b-3 | 01/16/2025 |
5 | Disposition of 6022 shares by Redmile Group, Llc of Fate Therapeutics subject to Rule 16b-3 | 01/31/2025 |
6 | Were Keeping An Eye On Fate Therapeutics Cash Burn Rate | 02/04/2025 |
7 | Acquisition by Dulac Edward J Iii of 425000 shares of Fate Therapeutics at 6.77 subject to Rule 16b-3 | 02/28/2025 |
8 | Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635 | 03/04/2025 |
9 | Fate Therapeutics Inc Q4 2024 Earnings Revenue Surpasses Estimates at 1. ... | 03/05/2025 |
10 | Needham Company LLC Reiterates Hold Rating for Fate Therapeutics | 03/06/2025 |
11 | Fate Therapeutics, Inc. Receives Average Recommendation of Hold from Analysts - Defense World | 03/13/2025 |
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |